Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotenoids | 36 | 2024 | 75 | 9.740 |
Why?
|
| Diet | 19 | 2024 | 1139 | 2.930 |
Why?
|
| beta Carotene | 6 | 2024 | 41 | 2.070 |
Why?
|
| Fruit | 11 | 2024 | 220 | 1.960 |
Why?
|
| Vegetables | 8 | 2024 | 262 | 1.800 |
Why?
|
| Prostatic Neoplasms | 9 | 2024 | 1547 | 1.670 |
Why?
|
| Milk, Human | 3 | 2024 | 300 | 1.520 |
Why?
|
| Intestinal Absorption | 3 | 2017 | 190 | 1.480 |
Why?
|
| Skin | 4 | 2024 | 518 | 1.090 |
Why?
|
| Dioxygenases | 3 | 2022 | 46 | 0.990 |
Why?
|
| Biomarkers | 6 | 2024 | 3080 | 0.980 |
Why?
|
| Anticarcinogenic Agents | 3 | 2022 | 56 | 0.930 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 4 | 2024 | 4 | 0.920 |
Why?
|
| Milk | 1 | 2024 | 119 | 0.840 |
Why?
|
| Nutrition Assessment | 1 | 2024 | 136 | 0.830 |
Why?
|
| Antioxidants | 2 | 2015 | 369 | 0.820 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2023 | 30 | 0.810 |
Why?
|
| Soybean Proteins | 2 | 2019 | 17 | 0.790 |
Why?
|
| Databases, Factual | 1 | 2024 | 1179 | 0.640 |
Why?
|
| Vitamins | 1 | 2017 | 108 | 0.540 |
Why?
|
| Biological Availability | 5 | 2018 | 137 | 0.520 |
Why?
|
| Dietary Fats | 1 | 2017 | 294 | 0.500 |
Why?
|
| Prostate | 6 | 2024 | 434 | 0.490 |
Why?
|
| Carcinogenesis | 5 | 2023 | 334 | 0.490 |
Why?
|
| Cancer Survivors | 1 | 2018 | 211 | 0.480 |
Why?
|
| Spectrum Analysis | 4 | 2024 | 65 | 0.470 |
Why?
|
| Health Promotion | 1 | 2018 | 389 | 0.470 |
Why?
|
| Lutein | 3 | 2023 | 15 | 0.470 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 237 | 0.470 |
Why?
|
| Dietary Supplements | 2 | 2015 | 473 | 0.470 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 2634 | 0.460 |
Why?
|
| Carbon Isotopes | 5 | 2015 | 277 | 0.430 |
Why?
|
| Zeaxanthins | 2 | 2023 | 9 | 0.420 |
Why?
|
| Vitamin A | 3 | 2023 | 58 | 0.410 |
Why?
|
| Genotype | 3 | 2024 | 2562 | 0.380 |
Why?
|
| Tissue Distribution | 5 | 2015 | 391 | 0.370 |
Why?
|
| Male | 27 | 2024 | 61470 | 0.370 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 2889 | 0.360 |
Why?
|
| Isotope Labeling | 4 | 2013 | 104 | 0.360 |
Why?
|
| Animals | 18 | 2024 | 34220 | 0.360 |
Why?
|
| Humans | 35 | 2024 | 125090 | 0.360 |
Why?
|
| Models, Biological | 1 | 2015 | 1459 | 0.340 |
Why?
|
| Infant | 6 | 2024 | 12477 | 0.320 |
Why?
|
| Liver | 5 | 2024 | 1744 | 0.310 |
Why?
|
| Beverages | 2 | 2019 | 100 | 0.300 |
Why?
|
| Glucose | 1 | 2013 | 877 | 0.300 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 3425 | 0.290 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2512 | 0.260 |
Why?
|
| Middle Aged | 10 | 2024 | 26918 | 0.250 |
Why?
|
| Half-Life | 2 | 2015 | 158 | 0.250 |
Why?
|
| Adult | 11 | 2024 | 29627 | 0.250 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2024 | 5 | 0.230 |
Why?
|
| Diet Records | 1 | 2024 | 74 | 0.220 |
Why?
|
| Female | 14 | 2024 | 66748 | 0.220 |
Why?
|
| Alkaloids | 1 | 2024 | 35 | 0.220 |
Why?
|
| Buchnera | 1 | 2003 | 1 | 0.210 |
Why?
|
| Kinetics | 2 | 2015 | 1332 | 0.210 |
Why?
|
| Symbiosis | 1 | 2003 | 64 | 0.210 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2024 | 193 | 0.200 |
Why?
|
| Infant Formula | 1 | 2023 | 96 | 0.200 |
Why?
|
| Mice | 9 | 2024 | 17634 | 0.200 |
Why?
|
| Oxygenases | 1 | 2022 | 4 | 0.200 |
Why?
|
| Genome, Bacterial | 1 | 2003 | 186 | 0.200 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2003 | 157 | 0.190 |
Why?
|
| Testosterone | 3 | 2023 | 533 | 0.190 |
Why?
|
| Work Performance | 1 | 2022 | 13 | 0.190 |
Why?
|
| Food | 2 | 2022 | 125 | 0.190 |
Why?
|
| Diet Surveys | 2 | 2020 | 98 | 0.180 |
Why?
|
| Ataxia | 1 | 2022 | 170 | 0.180 |
Why?
|
| Coinfection | 1 | 2022 | 171 | 0.180 |
Why?
|
| Parenting | 2 | 2021 | 332 | 0.170 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 93 | 0.170 |
Why?
|
| Parents | 3 | 2023 | 1026 | 0.170 |
Why?
|
| Cooking | 1 | 2020 | 38 | 0.170 |
Why?
|
| Swine | 1 | 2023 | 1207 | 0.170 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 668 | 0.160 |
Why?
|
| Meals | 1 | 2020 | 57 | 0.160 |
Why?
|
| Escherichia coli | 2 | 2011 | 985 | 0.160 |
Why?
|
| Carbon Radioisotopes | 1 | 2009 | 71 | 0.160 |
Why?
|
| Herbicides | 1 | 2009 | 12 | 0.160 |
Why?
|
| Phytochemicals | 1 | 2019 | 8 | 0.160 |
Why?
|
| Young Adult | 3 | 2024 | 9053 | 0.160 |
Why?
|
| Life Style | 1 | 2021 | 415 | 0.150 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2018 | 33 | 0.150 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 309 | 0.150 |
Why?
|
| Plant Extracts | 2 | 2015 | 121 | 0.150 |
Why?
|
| Infant, Premature | 1 | 2023 | 818 | 0.140 |
Why?
|
| Androgens | 2 | 2023 | 274 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 4393 | 0.140 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 1700 | 0.140 |
Why?
|
| Feeding Behavior | 2 | 2021 | 701 | 0.140 |
Why?
|
| Gene Expression | 2 | 2022 | 1561 | 0.140 |
Why?
|
| Exercise | 1 | 2023 | 812 | 0.140 |
Why?
|
| Environment | 1 | 2018 | 145 | 0.140 |
Why?
|
| Seizures | 1 | 2022 | 871 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2013 | 344 | 0.140 |
Why?
|
| Aged | 5 | 2019 | 19858 | 0.130 |
Why?
|
| Gerbillinae | 2 | 2013 | 55 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2022 | 660 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 835 | 0.130 |
Why?
|
| Colectomy | 1 | 2016 | 74 | 0.120 |
Why?
|
| Stereoisomerism | 1 | 2015 | 109 | 0.120 |
Why?
|
| Nutritive Value | 1 | 2015 | 91 | 0.120 |
Why?
|
| Self Report | 1 | 2018 | 518 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 870 | 0.120 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2024 | 7 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2018 | 1195 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 205 | 0.110 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 414 | 0.110 |
Why?
|
| Microbiota | 1 | 2018 | 389 | 0.100 |
Why?
|
| Safflower Oil | 1 | 2012 | 1 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 1711 | 0.100 |
Why?
|
| Cytokines | 1 | 2018 | 1288 | 0.100 |
Why?
|
| Plant Oils | 1 | 2012 | 33 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2018 | 1563 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2014 | 187 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2023 | 6152 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2021 | 1398 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2013 | 3054 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3298 | 0.090 |
Why?
|
| Inflammation | 1 | 2018 | 1445 | 0.090 |
Why?
|
| Weight Gain | 1 | 2013 | 400 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 1016 | 0.090 |
Why?
|
| Infant, Newborn | 1 | 2023 | 8205 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2013 | 466 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2012 | 343 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4405 | 0.070 |
Why?
|
| Hospitalization | 1 | 2016 | 1779 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 2396 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1026 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1893 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2021 | 762 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2023 | 14007 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2521 | 0.060 |
Why?
|
| Caco-2 Cells | 1 | 2024 | 94 | 0.060 |
Why?
|
| CD36 Antigens | 1 | 2024 | 37 | 0.060 |
Why?
|
| Hemoglobins | 2 | 2023 | 310 | 0.060 |
Why?
|
| Xenobiotics | 1 | 2024 | 26 | 0.060 |
Why?
|
| Melanins | 1 | 2023 | 18 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2016 | 3745 | 0.050 |
Why?
|
| Aphids | 1 | 2003 | 7 | 0.050 |
Why?
|
| Organ Size | 2 | 2016 | 436 | 0.050 |
Why?
|
| Accelerometry | 1 | 2023 | 60 | 0.050 |
Why?
|
| Heat-Shock Response | 1 | 2003 | 33 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2016 | 698 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 202 | 0.050 |
Why?
|
| Mammals | 1 | 2024 | 257 | 0.050 |
Why?
|
| Death | 1 | 2022 | 69 | 0.050 |
Why?
|
| Geranylgeranyl-Diphosphate Geranylgeranyltransferase | 1 | 2011 | 2 | 0.050 |
Why?
|
| Enterobacter | 1 | 2011 | 14 | 0.050 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2011 | 18 | 0.050 |
Why?
|
| Bioengineering | 1 | 2011 | 15 | 0.050 |
Why?
|
| Child | 4 | 2022 | 24391 | 0.050 |
Why?
|
| Proteome | 1 | 2003 | 243 | 0.050 |
Why?
|
| Gene Rearrangement | 1 | 2003 | 320 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2011 | 92 | 0.050 |
Why?
|
| Seasons | 1 | 2022 | 312 | 0.050 |
Why?
|
| Metabolomics | 1 | 2024 | 423 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2023 | 474 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 347 | 0.040 |
Why?
|
| Adolescent | 3 | 2022 | 19353 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 248 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 778 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2021 | 314 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2022 | 262 | 0.040 |
Why?
|
| Hydroxides | 1 | 2008 | 3 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 2715 | 0.040 |
Why?
|
| Potassium Compounds | 1 | 2008 | 8 | 0.040 |
Why?
|
| Organophosphates | 1 | 2008 | 16 | 0.040 |
Why?
|
| Base Sequence | 1 | 2003 | 3102 | 0.040 |
Why?
|
| North Carolina | 1 | 2018 | 59 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3890 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 888 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1398 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2008 | 256 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 3348 | 0.030 |
Why?
|
| Ferritins | 1 | 1997 | 98 | 0.030 |
Why?
|
| Ethanol | 1 | 2008 | 163 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 281 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1997 | 220 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 2452 | 0.030 |
Why?
|
| Infliximab | 1 | 2016 | 66 | 0.030 |
Why?
|
| Australia | 1 | 2016 | 138 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2016 | 147 | 0.030 |
Why?
|
| Plant Preparations | 1 | 2015 | 18 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2014 | 1064 | 0.030 |
Why?
|
| Cell Line | 1 | 2010 | 2758 | 0.030 |
Why?
|
| Plasma | 1 | 2015 | 98 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 258 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1105 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2015 | 344 | 0.030 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 166 | 0.030 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 72 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 4534 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 440 | 0.030 |
Why?
|
| Coconut Oil | 1 | 2012 | 2 | 0.030 |
Why?
|
| Consensus | 1 | 2016 | 641 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 504 | 0.020 |
Why?
|
| Cytochrome P-450 CYP11B2 | 1 | 2011 | 4 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1290 | 0.020 |
Why?
|
| Spleen | 1 | 2012 | 280 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3728 | 0.020 |
Why?
|
| Texas | 1 | 2020 | 3587 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 575 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 376 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 1997 | 854 | 0.020 |
Why?
|
| Testis | 1 | 2012 | 409 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7194 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1991 | 230 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 540 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2312 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2014 | 398 | 0.020 |
Why?
|
| DNA | 1 | 2014 | 1608 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 989 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2821 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6328 | 0.020 |
Why?
|
| United States | 1 | 2022 | 10912 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1498 | 0.020 |
Why?
|
| Glioma | 1 | 1991 | 492 | 0.020 |
Why?
|
| Anemia, Hypochromic | 1 | 1997 | 7 | 0.010 |
Why?
|
| Aluminum | 1 | 1997 | 12 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 1997 | 59 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1997 | 106 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1997 | 684 | 0.010 |
Why?
|
| Folic Acid | 1 | 1997 | 294 | 0.010 |
Why?
|
| Iron | 1 | 1997 | 270 | 0.010 |
Why?
|
| RNA Probes | 1 | 1991 | 30 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1991 | 261 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 309 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1991 | 344 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1991 | 980 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1991 | 686 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1991 | 663 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1997 | 6596 | 0.000 |
Why?
|
| Rats | 1 | 1991 | 3716 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1991 | 1662 | 0.000 |
Why?
|